🇺🇸 FDA
Patent

US 9198907

Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent

granted A61KA61K31/403A61K31/437

Quick answer

US patent 9198907 (Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent) held by PTC THERAPEUTICS, INC. expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/403, A61K31/437, A61K31/44, A61K31/444